Author Archive: Tracy Cooley

Tracy Cooley

Tracy serves as the Director of Events Communications and handles all communications for BIO’s events and emerging company policy issues. She loves blogging and podcasting on all things biotech and believes in the great potential of the industry, looking for every opportunity to spread the message far and wide. Nearly everyone in her family is a golfer, and as such, she has what many people have called a “natural” swing. Sometimes she even hits the ball. Tracy just finished her ninth marathon, and has nearly mastered the skill of one-foot-in-front-of-the-other (usually, sometimes the laces get in the way). The joy of her life is her five-year-old daughter Josephine.

Latest Posts

Drug Discovery & Development: Partnering for Success…and Survival

There are pressures on Big Pharma and biotech emerging companies alike to engage in more creative deal making to ensure positive outcomes for both parties, Ted Agres writes in Drug Discovery and Development. While the number of deals has remained relatively flat in 2011, the dollar amount of individual deals has increased overall. Oncology remains the most sought after category, followed by CNS, anti-infectives, metabolic diseases, dermatology and cardiovascular. Partnering activity at BIO events is on Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , ,

Tap into the Next Generation of Scientists

Biotechnology lab

The importance of mentoring and training students to become scientists has never been more critical as the U.S. aims to maintain its leadership in biotechnology. For students considering a future career path, biotech holds great promise. The industry currently employs 1.42 million Americans in high-wage, high quality jobs while supporting an additional 6.6 million jobs throughout the U.S.  On average, biotech jobs pay roughly two-thirds more than the average annual wage of the total U.S. Read More >

Business and Investments  |  1 Comment  |  Email This Post
Tags: , , ,

BIO Supports SBIR Reauthorization in Senate

Capitol

Last week, the Senate passed the National Defense Authorization Act (S. 1867), which included SBIR reauthorization through Senate Amendment 1115. This is a critical step toward ensuring that all innovative companies can compete for SBIR grants – based on the promise of their science rather than the structure of their capital.  Reauthorizing the program to allow small companies that receive the majority of their financing from venture capital to once again be eligible to compete Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: , , ,

4 Keys for Partnering Success

BIO Exhibition - 2011 BIO International Convention

Thinking of hosting partnering meetings at your BIO Exhibition booth in 2012? Abbott has been there, done that and learned what it takes to succeed and secure high-quality leads. “The greatest value of hosting partnering meetings within our booth is that it allows us to drive traffic, activity and interest within our own space,” said Michelle Calhoun, Abbott’s contract manufacturing marketing director. Abbott hosted nearly 60 meetings within our booth during three days of partnering Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , ,

15 Keys to Success from Fierce Biotech’s Top 15 Women in Biotech

lab_tech

This week, Fierce Biotech recognized 15 women who are leading the way in biotech. Each of them represents the drive and determination that it takes to succeed in the industry, but what do they recommend beyond these inherent qualities? We pulled together the list below based on their profiles so that others can learn from their experience (yes, that made the list). In no particular order: 1. Take risks 2. Have an entrepreneurial spirit 3. Read More >

Business of Biotech  |  1 Comment  |  Email This Post
Tags: ,